If you are experiencing serious side effects from a medication or an injury from a defective product you should first speak with your doctor. Then contact Brent M. Cordell for a free initial consultation and case evaluation. Our attorneys also represent family members of those who died a wrongful death due to dangerous drugs or defective products.

 

 

Cordell-Law.com

Brent M. Cordell,
Attorney at Law
1445 North Loop West,
Suite 700 Houston, TX.77008
Voice: (713) 248-5265
email: bcordelllaw@gmail.com

 

Follow Cordell Law on Twitter

The manufacturer of Digitek digoxin tablets has recalled the product, saying that it may have accidentally released pills that are double the normal thickness and carry twice the normal dose. The FDA is alerting doctors and the public to the recall via its MedWatch program. The agency notes that several reports of illness and injury have been reported. Digitek is distributed by Mylan Pharmaceuticals under a Bertek label and by UDL Laboratories under a UDL label, the Actavis press release notes. Pharmacies are currently contacting patients who may have received the double thickness pills. Digitek (digoxin), also known as Cardoxin, Digitek, Lanoxicaps or Lanoxin, was recalled in a Class I nationwide recall announced April 25, 2008.

The manufacturer of Digitek digoxin tablets has recalled the product, saying that it may have accidentally released pills carrying twice the normal dose. Digitek (digoxin), sold under Bertek and UDL labels, and also known as Cardoxin, Digitek, Lanoxicaps or Lanoxin, was recalled in a Class I nationwide recall announced April 25, 2008.

 

 

Digitek® (digoxin)

DIGITEK (digoxin) is one of the cardiac (or digitalis) glycosides, a closely related group of drugs having in common specific effects on the myocardium. These drugs are found in a number of plants. Digoxin is extracted from the leaves of Digitalis lanata. The term “digitalis” is used to designate the whole group of glycosides. The glycosides are composed of two portions: a sugar and a cardenolide (hence “glycosides”).

All Digitek digoxin tablets on the U.S. market were recalled by their manufacturer, Actavis, in late April 2008. According to the Food and Drug Administration, a manufacturing mistake led to some of the Digitek digoxin tablets being made with twice the intended level of the active ingredient, digoxin (digitalis).
The double dose of digoxin in the tablets is toxic. Digitalis is a very powerful chemical; even its source, the flowering plant foxglove (Digitalis purpurea), is poisonous. Digitek digoxin tablets are a prescription-only treatment for heart conditions such as irregular heart beat and heart failure. Although the generic drug digoxin is sold by various pharmaceutical companies under different names (such as Lanoxin and Digitek) and in various forms (tablet, elixir, liquid-filled capsules, intravenous injection), it is only the Digitek digoxin tablets that were recalled. All lots and all dosage strengths of the Digitek digoxin tables were recalled. The nationwide Digitek recall was of the Digitek tablets distributed by UDL Laboratories under the label “UDL” and Mylan Pharmaceuticals under the label “Bertek.” If you as a patient have been prescribed either of these brands of Digitek digoxin tablets, contact your physician immediately.

If you took Digitek, Cardoxin, Lanoxin or Lanoxicaps and suffered from overdose, it could be due to taking defective tablets containing twice the active ingredient as approved. Symptoms of digoxin overdose may include any of the following: nausea, vomiting, decreased appetite, diarrhea, confusion, seizures, hallucinations, light "halos" around objects, green or yellow vision, fatigue, irregular heartbeats, and abnormally fast or slow heartbeats.